1. Introduction {#sec1}
===============

Anisi stellati fructus (ASF) is fruit that comes from the evergreen aromatic tree, *Illicium verum* Hook. f. According to *The Great Pharmacopoeia* written by Li Shi Zhen, published in 1596, the fruit of *Illicium verum* Hook. f. (Chinese star anise) has been used as a remedy for infectious diseases. ASF has long been used as a food as well as for medical purposes because of its effect on eliminating odor and relieving symptoms such as high fever, diarrhea, and vomiting \[[@B1]\]. Additionally, Tamiflu, a treatment for swine-origin influenza A, was developed based on the components of ASF \[[@B2]\].

Chronic myeloid leukemia (CML) is considered to be a myeloproliferative neoplasm characterized by the expansion of a clone of hematopoietic cells that carries the abnormal Philadelphia chromosome and fused *Bcr-Abl* gene \[[@B3]\]. Bcr-Abl is a constitutively active cytoplasmic tyrosine kinase \[[@B4]\]. Bcr-Abl fusion protein is present in 95% of CML cases and 20%--30% of acute lymphoblastic leukemia cases \[[@B5], [@B6]\]. For these reasons, p210^Bcr-Abl^ is a major target of tyrosine kinase inhibitors (TKIs) \[[@B7]\]. CML is diagnosed in the chronic phase and is transformed into the acute phase in an average of 2-3 years, resulting in mortality within a few months despite antileukemic combination therapy \[[@B8], [@B9]\].

Imatinib (brand name: Gleevec, Novartis; formerly called STI571) is a relatively specific inhibitor of the Bcr-Abl tyrosine kinase, which has efficacy in CML \[[@B10]\]. Although survival from CML was increased by imatinib (IM), drug resistance by mutated forms of Bcr-Abl led to the development of new drugs such as dasatinib, nilotinib, bosutinib, and ponatinib \[[@B11]\]. The K-562 CML cell line is highly resistant to various stimuli. However, the development of new drugs often causes resistance to these drugs \[[@B12]\].

To date, some studies have shown a correlation between infection and cancer, and approximately 2 million emerging cancer cases are due to infections from microorganisms \[[@B13]--[@B15]\]. Numerous studies have shown that antimicrobial peptides have cytotoxic effects on cancer cells and have the possibility of being used in anticancer therapy either alone or in combination with other conventional drugs. An increasing number of studies have shown that some of the cationic antimicrobial peptides, which are toxic to bacteria but not to normal mammalian cells, exhibit a broad spectrum of cytotoxic activities against cancer cells \[[@B16], [@B17]\]. Our previous study has shown that ASF contains 49 identified compounds, of which 35 compounds were analyzed to have target genes related to antimicrobial activities \[[@B18]\]. However, there has been minimal research on the anticancer effects of ASF. Only ASF has been reported to inhibit the metastasis and angiogenesis of malignant cancer cells \[[@B19]\]. In the present study, the 49 identified compounds of ASF were further investigated for their efficacy against cancer using systemic pharmacological analysis. The results showed that 20% of the total ASF compounds were associated with CML. Based on this result, we characterized the antileukemic potential of ASF against K-562 CML cells. The results showed that the ASF extract (ASFE) either alone or in combination with IM significantly reduced the amount of p210^Bcr-Abl^ protein, suggesting further studies to confirm ASF as an effective antileukemic adjuvant.

2. Materials and Methods {#sec2}
========================

2.1. Chemicals and Reagents {#sec2.1}
---------------------------

IM was purchased from Sigma-Aldrich (St. Louis, MO, USA). Dulbecco\'s phosphate-buffered saline (D-PBS) was purchased from Gibco (Grand Island, NY, USA). High-pressure liquid chromatography- (HPLC-) grade methanol and water were obtained from JT Baker (Phillipsburg, NJ, USA). The Cell Counting Kit-8 (CCK-8) was obtained from Dojindo Molecular Technologies (Rockville, MD, USA). Anti-Bcr and secondary antibodies were purchased from Cell Signaling Technology (Danvers, MA, USA). Antibody specific to beta-actin was purchased from Sigma-Aldrich. The 4-anisaldehyde, 4-prophenylanisole, and other chemicals were purchased from Sigma-Aldrich.

2.2. Systemic Pharmacological Analyses of ASF {#sec2.2}
---------------------------------------------

### 2.2.1. Identification of ASF Compounds {#sec2.2.1}

To search for identified compounds in ASF and to investigate the relationship between the compounds and cancers, the Traditional Chinese Medicine Systems Pharmacology (TCMSP, [http://lsp.nwu.edu.cn/](http://lsp.nwu.edu.cn/))) database and analysis platform were used. The 49 compounds were found in ASF, and all diseases related to each compound were recorded. After screening a total of 49 compounds, 33 compounds were found to have relationships with cancer categories. Among them, 10 CML-related compounds were identified. To screen bioactive compounds of these 10 CML-related compounds, five parameters related to absorption, distribution, metabolism, and excretion were used: molecular weight (MW), oral bioavailability (OB), Caco-2 permeability (Caco-2 cells), drug likeness (DL), and drug half-life (HL) \[[@B20]--[@B22]\].

### 2.2.2. Target Collection {#sec2.2.2}

Molecular targets of the 10 CML-related compounds and the official gene information were acquired and listed using the UniProt database ([http://www.uniprot.org](http://www.uniprot.org/)).

### 2.2.3. Network Construction {#sec2.2.3}

To visualize the 10 CML-related compounds and their possible targets, a compound (C)-target (T) network was constructed using Cytoscape 3.7.1, an open-source bioinformatics platform for visualizing molecular interaction networks (<https://cytoscape.org/>). In the network, the node denoted either compounds or target proteins, and the edges represented compound-target connections.

2.3. Preparation of ASF {#sec2.3}
-----------------------

Dried fruits of ASF (1.0 g) obtained from Kwangmyungdang Medical Herbs (Ulsan, Republic of Korea) were broken into pieces, ground, and mixed with 10 mL of methanol. The mixture was vortexed and sonicated for 30 min at room temperature. The resulting mixture was centrifuged at 3,000 rpm for 30 min at room temperature. The supernatant was carefully collected and filtered through a 0.2 *μ*m syringe filter (BIOFACT™, Yuseong-Gu, Republic of Korea). The filtrate was evaporated using a pressured gas blowing concentrator (MGS-2200; EYELA, Chula Vista, CA, USA). The yield of the ASF was 5%.

2.4. Chemical Profiling of ASF by HPLC {#sec2.4}
--------------------------------------

### 2.4.1. Chromatography Conditions {#sec2.4.1}

Analysis was performed using an Agilent 1290 HPLC system (Agilent Technologies, Palo Alto, CA, USA) consisting of a quaternary pump, an autosampler, a column oven, and a diode-array detector. The data were processed using ChemStation software, rev. B. 03. 02 (Agilent). To separate the sample, an ACQUITY UPLC BEH C18 column (2.1 × 100 mm, 1.7 *μ*m; Waters, Milford, MA, USA) was used. The mobile phase was comprised of 0.1% formic acid in distilled water (A) and acetonitrile (B). The column temperature was maintained at 40°C. The analysis was conducted at a flow rate of 1.0 mL/min with PDA detection wavelengths of 254 nm and 275 nm. The injection volume was 5 *μ*L.

### 2.4.2. Preparation of Standard Solutions {#sec2.4.2}

The standard stock solutions of 4-anisaldehyde and 4-prophenylanisole were prepared in methanol and stored at 4°C. A working standard solution was prepared by serial dilution of stock solutions with methanol. All calibration curves were obtained from assessments of peak areas of standard solutions in the following concentration ranges: 4-anisaldehyde, 0.10--2.00 *μ*g/mL; 4-prophenylanisole, 0.10--2.00 *μ*g/mL.

### 2.4.3. Preparation of Sample Solution {#sec2.4.3}

The resulting solution of ASFE was filtered through a 0.2 *μ*m syringe filter and injected into the HPLC instrument.

2.5. Cell Culture {#sec2.5}
-----------------

Chronic myeloid K-562 leukemia cells were obtained from the American Type Culture Collection (Manassas, VA, USA) and maintained in RPMI 1640 containing 10% (v/v) heat-inactivated fetal bovine serum (Sigma-Aldrich) and 1% (v/v) penicillin/streptomycin (Gibco/BRL, Grand Island, NY) at 37°C in a 5% (v/v) CO~2~ incubator.

2.6. Cell Viability Assay {#sec2.6}
-------------------------

Cell viability was determined using the CCK-8 assay according to the manufacturer\'s instructions. K-562 cells were seeded at a density of 1 × 10^4^/well in a 96-well plate. After incubation for 24 h, the cells were treated with dimethyl sulfoxide or various concentrations of ASFE for 24 h at 37°C in an incubator with a 5% CO~2~ atmosphere. The cells were then incubated with 10 *μ*L of CCK-8 reagent for 4 h at 37°C. Absorbance was measured at 450 nm using an ELISA microplate reader (Tecan, Mannedorf, Switzerland). Data are presented as the percentage viabilities of untreated cells (100%). The assay was independently repeated three times.

2.7. Western Blot Analysis {#sec2.7}
--------------------------

After treatment with ASFE, IM, and ASFE + IM by either a dose-dependent or time-dependent manner, K-562 cells were harvested by centrifugation at 4°C, washed once with ice-cold D-PBS, resuspended in lysis buffer (50 mM Tris (pH7.5), 2 mM EDTA, 100 mM NaCl, and 1% NP-40) containing protease inhibitor cocktail (Sigma-Aldrich), and incubated for 30 min at 4°C. Following centrifugation for 15 min at 13,000 rpm at 4°C, the protein concentration of the lysate was determined using a bicinchoninic acid (BCA) Protein Assay Kit (Thermo Fisher Scientific, Waltham, MA, USA), according to the manufacturer\'s instructions. 30 *μ*g of total protein was separated on a 6% or 7% sodium dodecyl sulfate-polyacrylamide gel and electroblotted onto polyvinylidene difluoride (PVDF) membranes (Bio-Rad, Hercules, CA, USA). The blots were incubated with a blocking solution (5% skim milk) for 1 h at room temperature, followed by incubation overnight with the primary antibodies (anti-Bcr, 1 : 3,000 dilution; anti-beta-actin, 1 : 1,000 dilution) at 4°C. The blots were then washed three times with Tween-20/Tris-buffered saline (TTBS), followed by incubation with the appropriate horseradish peroxide-conjugated secondary antibodies (1 : 3,000 dilution) for 1 h at room temperature, and then washed with TTBS. Immunoreactive bands were visualized using the Enhanced Chemiluminescence Detection Solution (ECL Plus; Thermo Fisher Scientific). ImageJ software was used to quantitate the band densities.

2.8. Quantification of Apoptosis by Annexin V Labeling {#sec2.8}
------------------------------------------------------

Apoptosis was quantified using an annexin V and 7-AAD Kit (Millipore, Hayward, CA, USA) according to the manufacturer\'s instructions. Briefly, after 1 × 10^6^ K-562 cells were seeded in a 60 mm cell culture dish, ASFE (2 *μ*g/mL), IM (2.0 *μ*mol), or their combination was added. Following incubation for 24 h at 37°C in a 5% CO~2~ incubator, the cells were collected and incubated with annexin-V and 7-AAD for 20 min at room temperature in the dark. The events for live, dead, and early (annexin V+/7-AAD+) cells were counted using the Muse cell analyzer (Merck Millipore, Billerica, MA, USA).

2.9. Statistical Analysis {#sec2.9}
-------------------------

Statistical analysis was performed using SPSS statistical software for Windows, version 23 (IBM, Armonk, NY, USA). Data are expressed as the mean ± standard deviation (SD) of triplicate determinations. Differences in means between groups were subjected to one-way analysis of variance followed by the least-significant multiple comparison test and independent *t*-test. *P* values \<0.05 were considered significant differences.

3. Results {#sec3}
==========

3.1. Screening 33 Cancer-Related Compounds {#sec3.1}
------------------------------------------

According to the TCMSP database, ASF contained 49 identified compounds. Every compound and its related diseases were investigated, and 33 cancer-related compounds were screened ([Table 1](#tab1){ref-type="table"}).

3.2. Collecting 10 CML-Related Active Compounds and Systemic Pharmacological Analyses {#sec3.2}
-------------------------------------------------------------------------------------

Ten CML-related compounds and the analyzed results are shown in [Table 2](#tab2){ref-type="table"}. To search bioactive compounds, the criteria of each parameter were suggested. Molecular weights from 180 to 500 Daltons were recognized as comparatively more druggable \[[@B23]\]. Oral bioavailability (OB) ≥30% and drug likeness ≥0.18 were used as ideal drug characteristics \[[@B24], [@B25]\]. Caco-2 cell permeability was tested using an *in vitro* experiment with the Caco-2 human intestinal cell line. Drug half-life (*t*1/2) represented how long it took for the drug to be internalized and reduced by half; a drug half-life ≤4 h was classified as the fast elimination group, between 4 and 8 h as the midelimination group, and ≥8 h as the slow-elimination group \[[@B20], [@B21]\].

Among the 10 CML-related compounds, luteolin (MW = 286.25, OB (%) = 36.16, Caco-2 = 0.19, DL = 0.25, and HL = 15.94), kaempferol (MW = 286.25, OB (%) = 41.88, Caco-2 = 0.26, DL = 0.24, and HL = 14.74), and quercetin (MW = 302.25, OB (%) = 46.43, Caco-2 = 0.05, DL = 0.28, and HL = 14.4) largely met the suggested criteria and have been reported as representative antibacterial compounds in previous studies \[[@B26]--[@B28]\], including our study \[[@B18]\]. Additionally, luteolin exhibited an antibacterial action that suppressed the activity of bacterial DNA topoisomerases 1 and 2 and reduced the synthesis of nucleic acids and proteins \[[@B29]\] and was also known to have antioxidant, anticancer, anti-inflammatory, and neuroprotective effects \[[@B30]\]. Kaempferol is a flavonoid and possesses anti-inflammatory, antioxidant, anticancer, and antibacterial activities \[[@B31]--[@B33]\]. It has been shown to be effective against acne-induced *Propionibacterium acnes* and *Helicobacter pylori* found in the stomach \[[@B34]\]. Quercetin is a compound that plays an important role in inflammation, cancer, aging, cell signaling, proapoptotic effects, antiproliferative effects, antioxidant effects, and growth suppression \[[@B35], [@B36]\]. Astragalin (MW = 448.41, OB (%) = 14.03, Caco-2 = -1.34, DL = 0.74, and HL = N/A) has been reported to inhibit autophagosome formation in airways \[[@B37]\]. Honokiol (MW = 266.36, OB (%) = 60.67, Caco-2 = 1.43, DL = 0.15, and HL = 2.88) has been shown to have antitumorigenic, anti-inflammatory, and antioxidant effects \[[@B38]--[@B40]\]. (+)-Catechin (MW = 290.29, OB (%) = 54.83, Caco-2 = −0.03, DL = 0.24, and HL = 0.61) is a well-known phenolic compound found in tea and wine.

3.3. Network Construction of 10 CML-Related Compounds and Their Related Targets {#sec3.3}
-------------------------------------------------------------------------------

To visualize the target genes of 10 CML-related compounds, a compound (C)-target (T) network was established. A total of 313 target proteins were collected from the TCMSP, and the official gene names of the targets were obtained from the UniProt database. [Figure 1](#fig1){ref-type="fig"} shows that the C-T network revealed interactions between 10 CML-related compounds and 313 target genes. The nodes showed the 10 CML-related compounds and the target genes, and the edges represented the interaction of compounds and targets. The size of nodes was related to the degrees. Quercetin (degree = 77) had the greatest interaction with targets, followed by luteolin (degree = 56), kaempferol (degree = 36), salicylic acid (degree = 35), 2-methyl-N-phenylmaleimide (degree = 29), *R*-linalool (degree = 20), honokiol (degree = 18), astragalin (degree = 16), CHEBI:7 (degree = 15), and (+)-catechin (degree = 10).

3.4. HPLC Analysis of ASFE {#sec3.4}
--------------------------

The main components of ASFE were determined using an HPLC system to evaluate the quality of ASFE. Because 4-anisaldehyde and 4-prophenylanisole \[(E)-anethole\] have been reported to be the main compounds of ASFE, we used them as standards and conducted the analysis. As shown in the representative chromatographic fingerprint of ASFE, the main components of ASFE were 4-anisaldehyde and 4-prophenylanisole ([Figure 2](#fig2){ref-type="fig"}).

3.5. Effect of ASFE on the Cell Viability of K-562 Cells {#sec3.5}
--------------------------------------------------------

The possible cytotoxic effect of ASFE (0--8 *μ*g/mL) on K-562 cells was assessed ([Figure 3](#fig3){ref-type="fig"}). ASFE significantly inhibited the proliferation of K-562 cells in a dose-dependent manner. The IC50 value of ASFE was approximately 4.03 ± 2.3 *μ*g/mL (^*∗*^*P* \< 0.05; ^*∗∗*^*P* \< 0.01).

3.6. ASFE Treatment on K-562 Cells Decreases the Amount of p210^*Bcr-Abl*^ in a Time-dependent Manner {#sec3.6}
-----------------------------------------------------------------------------------------------------

ASFE or IM was used to treat K-562 cells, and the p210^Bcr-Abl^ protein steady-state levels in the total lysate were analyzed by western blotting ([Figure 4](#fig4){ref-type="fig"}). 2 *μ*mol IM was subjected based on previous studies \[[@B41]\]. The p210^Bcr-Abl^ protein levels were decreased after treatment with ASFE or IM on K-562 cells in a time-dependent manner (^*∗*^*P* \< 0.05; ^*∗∗*^*P* \< 0.01).

3.7. ASFE Enhanced IM-Induced Destabilization of p210^*Bcr-Abl*^ {#sec3.7}
----------------------------------------------------------------

[Figure 5](#fig5){ref-type="fig"} shows that when both ASFE and IM were added together to K-562 cells, the level of p210^Bcr-Abl^ was diminished compared to that of the lanes containing K-562 cells after treatment with IM or ASFE, indicating that the combined treatment of K-562 cells by ASFE and IM was more potent than each one separately.

3.8. Assessment of ASFE- and IM-Inducing Cell Death Mechanisms on K-562 Cells {#sec3.8}
-----------------------------------------------------------------------------

Apoptosis, necrosis, and autophagy are well-known cell death mechanisms. To observe apoptosis and necrosis, we conducted flow cytometry using annexin V and 7-AAD staining. After 16 h treatment of IM, ASFE, or IM + ASFE, the cells were stained with both annexin V and 7-AAD. The results showed that, in the control, \>85% of the cells survived; the cell population decreased to 82.79% for the IM, 9.54% for the ASFE, and 0% for the IM + ASFE. The late apoptotic/necrotic cell population increased to 13.03% (IM), 36.33% (ASFE), and 42.89% (ASFE + IM). The early apoptotic cell population increased to 0.93% (IM), 0.00% (ASFE), and 0.00% (ASFE + IM) ([Figure 6](#fig6){ref-type="fig"}). The cell populations of late apoptosis/necrosis significantly increased, but increased cell population during early apoptosis was rare. Based on these results, we postulated that K-562 cells were involved in an alternate pathway and were not involved in apoptosis. These results also showed that K-562 cell killing was significant after treatment with ASFE.

4. Discussion {#sec4}
=============

Traditionally, ASF has been used in Chinese medicine for the treatment of skin inflammation, stomach aches, and rheumatic pain \[[@B1]\]. For decades, herbal medicine has been used as an adjunct in chemotherapy for cancer treatment, demonstrating their synergistic roles in enhancing efficacy, ameliorating side effects, and reducing drug resistance \[[@B42]\]. However, there have been few scientific studies describing the anticancer effects of ASF.

CML is a clonal myeloproliferative disorder characterized by the presence of a constitutive tyrosine kinase activity of the fusion oncogene, *Bcr-Abl* \[[@B11]\]. Bcr-Abl protein induces cellular transformation by activating the signaling molecules, STAT5 and Akt \[[@B43]\]. As a first-line treatment, TKI-targeted Bcr-Abl was expected to treat CML effectively, but it has shown drug resistance, so the next generation of drugs from imatinib has been required \[[@B44]\]. Bcr-Abl T315I is the most frequent resistant mutation to tyrosine kinase inhibitors \[[@B45]\]. Following imatinib, the second-generation inhibitors such as dasatinib, nilotinib, and bosutinib and third-generation inhibitor such as ponatinib have been used to treat resistant cases of CML. Ponatinib has been developed to overcome the T315I mutation. The next candidates of tyrosine kinase inhibitors, including bafetinib, danusertib, rebastinib, tozasertib, HG-7-85-01, GNF-2, and 1,3,4-thiadiazole derivatives are presently undergoing approval as the next generation of therapeutic agents \[[@B46]\]. However, the issue of drug resistance is a rapidly increasing problem, and alternatives that are less toxic are urgently needed. Accordingly, this study aimed at providing the potential for exploring new therapies that are less harmful and more effective.

In the present study, we used a systemic pharmacological approach, filtered active compounds of ASF, constructed the compound-target network, and screened cancer-related compounds of ASF. ASF was found to contain 49 identified compounds, and 33 compounds were active in biological pathways related to cancers. Moreover, 10 of the 33 were classified as being associated with CML. Additionally, the compound-target network showed multiple compounds and multiple targeting characteristics of ASF. Multiple compounds and multiple targeting actions of other herbal medicines such as licorice \[[@B47]\], Xiao-Chaihu Decoction, Da-Chaihu Decoction \[[@B48]\], Pulsatillae Radix, Baekduong-tang \[[@B49], [@B50]\], and Bulsusan \[[@B51]\] have also been studied. Based on our results, we propose that ASF is a potential antileukemic agent.

Experiments were conducted to confirm this possibility. First, the active components of ASF were extracted. According to previous studies, the extraction of ASF could be conducted using several extraction techniques such as hydrodistillation, steam distillation, solvent extraction, supercritical fluid CO~2~ extraction, hydrodistillation-headspace solvent microextraction, and microwave-assisted extraction \[[@B52], [@B53]\]. In our study, a combination of solvent extraction and sonication, followed by pressured gas blowing concentration, was used. To obtain the maximum extraction ASF, methanol was used as a solvent \[[@B54]\], followed by sonication to increase the extraction efficiency. The 4-prophenylanisole was one of the main compounds of ASF and accounted for 94% of the essential oil \[[@B55]\]. Another major component of ASF was 4-anisaldehyde, which is used as a food fragrance and reported to have antifungal and saliva-enhancing effects \[[@B56]\]. In this study, the main compounds of 4-prophenylanisole and 4-anisaldehyde were identified in the ASFE using HPLC.

The ASFE and ASFE + IM combination showed potent antileukemic effects by decreasing the p210^Bcr-Abl^ levels. Because leukemic stem cells do not respond to TKI, when the drug supply is stopped, the cells can continuously multiply to allow the disease to persist. Moreover, the combination of treatment targets results, more efficiently, in alternative surviving mechanisms of cancer cells such as autophagy \[[@B16]\].

Our results showed that ASFE combined with IM resulted in the significant death of K-562 cells. The results suggested the feasibility of further research to identify cell death mechanisms following a decrease in Bcr-Abl. In addition, our next phase of research will be to verify the effects of 10 CML-related compounds as well as two representative compounds of ASF, 4-anisaldehyde and 4-prophenylanisole, on CML. The workflow scheme of our study is summarized in [Figure 7](#fig7){ref-type="fig"}.

5. Conclusion {#sec5}
=============

We have identified 10 CML-related compounds of ASF using systematic pharmacological analyses. The ASF extract significantly induced cell death of K-562 cells. In addition, combined treatment with ASFE and IM led to a significant decrease of Bcr-Abl protein levels. The results showed that ASF is a promising source of effective chemotherapeutic adjuvants and is a candidate, in combination with other chemotherapeutic drugs, for the treatment of CML patients, to ameliorate the side effects and overcome resistance. Although we do not know the exact mechanisms of the 10 compounds of ASF and their antileukemic effects, this study is the first to report the antileukemic effects of ASF on K-562 CML cells, which should prompt further mechanistic studies of these antileukemic compounds.

This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2018R1D1A3B07049092).

Data Availability
=================

All data used to support the findings of this study are included within the article.

Conflicts of Interest
=====================

The authors declare that they have no conflicts of interest.

Authors\' Contributions
=======================

Won G. An designed the experiments. Youn Sook Kim performed the experiments, and Su Yeon Suh analyzed the data. Youn Sook Kim and Won G. An wrote the paper. Chul Won Lee, Sang Yull Lee, and Yong Tae Ahn reviewed and edited the manuscript. All the authors read and approved the final manuscript.

![The network of 10 CML-related compounds and their related target genes. Triangle nodes represent compounds and circular nodes represent targets. Node size is relative to the degree, and the edges demonstrate the interaction between nodes.](ECAM2019-6959764.001){#fig1}

![Chromatograms of two major components (4-anisaldehyde and 4-prophenylanisole) identified in Anisi stellati fructus extract (ASFE). (a) Chromatograms of the standard mixture. (b) Chromatograms of the major components in ASFE. The chromatograms were obtained at 254.5 and 275 nm.](ECAM2019-6959764.002){#fig2}

![Cytotoxicity of the ASFE on K-562 cells. The cells (1 × 10^4^/well) were determined using a CCK-8 assay.](ECAM2019-6959764.003){#fig3}

![Changes in the p210^Bcr-Abl^ protein levels treated with ASFE or imatinib (IM). K-562 cells were treated with (a) ASFE (2 *μ*g/mL) or (b) IM (2 *μ*mol) for increasing time periods (0--16 h). The p210^Bcr-Abl^ protein steady-state levels in the total lysates were analyzed by western blotting. Relative protein levels versus controls (beta-actin) were determined by densitometry. Data are the mean ± SD of three independent experiments (^*∗*^*P* \< 0.05; ^*∗∗*^*P* \< 0.01).](ECAM2019-6959764.004){#fig4}

![ASFE + IM combined therapy led to a decrease of p210^Bcr-Abl^. K-562 cells were treated with IM (2 *μ*mol), ASFE (2 *μ*g/mL), and IM + ASFE combination for 12 h at 37°C. The p210^Bcr-Abl^ protein levels in the total lysate were analyzed by western blotting (^*∗*^*P* \< 0.05; ^*∗∗*^*P* \< 0.01).](ECAM2019-6959764.005){#fig5}

![Apoptosis assessment of the effects of IM, ASFE, and IM + ASFE on K-562 cells. After 16 h of treatment, the cells were stained with annexin V/7-AAD reagent and cytometric analysis was performed using a MUSE™ cell analyzer. (a) Control, (b) IM, (c) ASFE, (d) IM + ASFE.](ECAM2019-6959764.006){#fig6}

![A workflow scheme illustrating the hypothesis that compounds of ASF having antileukemic potential can be identified using systematic pharmacological approaches; the experimental proof was that ASF was effective in killing of K-562 chronic myeloid leukemia cells.](ECAM2019-6959764.007){#fig7}

###### 

The 33 compounds and their related cancers.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Active compounds                                                                                                       Related cancers
  ---------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------
  C09628                                                                                                                 Bladder cancer\
                                                                                                                         Breast cancer\
                                                                                                                         Cancer, unspecific\
                                                                                                                         Colorectal cancer\
                                                                                                                         Genitourinary tumors\
                                                                                                                         Lung cancer\
                                                                                                                         Oropharyngeal squamous cell carcinoma\
                                                                                                                         Prostate cancer\
                                                                                                                         Renal cell carcinoma

                                                                                                                         

  Kaempferol                                                                                                             Prostate cancer\
                                                                                                                         Adrenocorticotropic hormone-secreting pituitary tumors\
                                                                                                                         Bladder cancer\
                                                                                                                         Pancreatic cancer\
                                                                                                                         Renal cell carcinoma\
                                                                                                                         Testicular cancer\
                                                                                                                         Thyroid follicular carcinoma\
                                                                                                                         Breast cancer\
                                                                                                                         Colorectal cancer\
                                                                                                                         Genitourinary tumors\
                                                                                                                         Lung cancer\
                                                                                                                         Head and neck cancer\
                                                                                                                         Malignant mesothelioma\
                                                                                                                         Meningioma\
                                                                                                                         Oropharyngeal squamous cell carcinoma\
                                                                                                                         Chronic myelogenous leukemia (CML)\
                                                                                                                         Gastrointestinal stromal tumors (GIST)\
                                                                                                                         Hematological malignancies\
                                                                                                                         HER2-positive\
                                                                                                                         Metastatic breast cancer\
                                                                                                                         Melanoma\
                                                                                                                         Multiple myeloma\
                                                                                                                         Non-small-cell lung cancer\
                                                                                                                         Ovarian cancer\
                                                                                                                         Refractory hematological malignancies\
                                                                                                                         Solid tumors\
                                                                                                                         Malignancies\
                                                                                                                         Gliomas\
                                                                                                                         Colon cancer\
                                                                                                                         Acute promyelocytic leukemia\
                                                                                                                         Chronic lymphocytic leukemia\
                                                                                                                         Prostate cancer (hormone-refractory)\
                                                                                                                         Waldenstrom\'s macroglobulinemia\
                                                                                                                         Solid tumor\
                                                                                                                         Cancer (multidrug-resistant)\
                                                                                                                         Chondrosarcoma\
                                                                                                                         Hormone-refractory prostate cancer\
                                                                                                                         Kaposi\'s sarcoma\
                                                                                                                         Breast neoplasms\
                                                                                                                         Colorectal neoplasms\
                                                                                                                         Ovarian neoplasms\
                                                                                                                         Urinary bladder neoplasms\
                                                                                                                         Bronchiolar carcinoma\
                                                                                                                         Cervical cancer\
                                                                                                                         Rectal neoplasms\
                                                                                                                         Chronic myeloid leukemia\
                                                                                                                         Gastrointestinal cancers\
                                                                                                                         Urological cancers\
                                                                                                                         Non-small-cell lung carcinoma\
                                                                                                                         Gastrointestinal cancers\
                                                                                                                         Gastrointestinal neoplasms\
                                                                                                                         Head and neck neoplasms\
                                                                                                                         Neoplasms\
                                                                                                                         Precursor cell\
                                                                                                                         Lymphoblastic leukemia-lymphoma

                                                                                                                         

                                                                                                                         

  ZINC02040970                                                                                                           Bladder cancer\
                                                                                                                         Breast cancer\
                                                                                                                         Cancer, unspecific\
                                                                                                                         Carcinoma in situ unspecified\
                                                                                                                         Colorectal cancer\
                                                                                                                         Genitourinary tumors\
                                                                                                                         Lung cancer\
                                                                                                                         Oropharyngeal squamous cell carcinoma\
                                                                                                                         Prostate cancer\
                                                                                                                         Renal cell carcinoma

                                                                                                                         

  (1R,5R,7S)-4,7-Dimethyl-7-(4-methylpent-3-enyl)bicyclo\[3.1.1\]hept-3-ene                                              Bladder cancer\
                                                                                                                         Breast cancer\
                                                                                                                         Cancer, unspecific\
                                                                                                                         Carcinoma in situ, unspecified\
                                                                                                                         Colorectal cancer\
                                                                                                                         Genitourinary tumors\
                                                                                                                         Lung cancer\
                                                                                                                         Malignant mesothelioma\
                                                                                                                         Oropharyngeal squamous cell carcinoma\
                                                                                                                         Prostate cancer\
                                                                                                                         Renal cell carcinoma

                                                                                                                         

  1,8-Cineole                                                                                                            Colon cancer\
                                                                                                                         Bladder cancer\
                                                                                                                         Breast cancer\
                                                                                                                         Cancer, unspecific\
                                                                                                                         Carcinoma in situ, unspecified\
                                                                                                                         Colorectal cancer\
                                                                                                                         Genitourinary tumors\
                                                                                                                         Lung cancer\
                                                                                                                         Oropharyngeal squamous cell carcinoma\
                                                                                                                         Prostate cancer

                                                                                                                         

  3-O-Feruloylquinic acid                                                                                                Bladder cancer\
                                                                                                                         Breast cancer\
                                                                                                                         Cancer, unspecific\
                                                                                                                         Carcinoma in situ, unspecified\
                                                                                                                         Colorectal cancer\
                                                                                                                         Genitourinary tumors\
                                                                                                                         Lung cancer\
                                                                                                                         Malignant mesothelioma\
                                                                                                                         Oropharyngeal squamous cell carcinoma\
                                                                                                                         Prostate cancer\
                                                                                                                         Renal cell carcinoma\
                                                                                                                         Pancreatic cancer\
                                                                                                                         Tumors

                                                                                                                         

  Anisketone                                                                                                             Gliomas\
                                                                                                                         Bladder cancer\
                                                                                                                         Breast cancer\
                                                                                                                         Cancer, unspecific\
                                                                                                                         Carcinoma in situ, unspecified\
                                                                                                                         Colorectal cancer\
                                                                                                                         Genitourinary tumors\
                                                                                                                         Lung cancer\
                                                                                                                         Malignant mesothelioma\
                                                                                                                         Meningioma\
                                                                                                                         Oropharyngeal squamous cell carcinoma\
                                                                                                                         Prostate cancer\
                                                                                                                         Renal cell carcinoma\
                                                                                                                         Colon cancer\
                                                                                                                         Pancreatic cancer

                                                                                                                         

  Copaene                                                                                                                Bladder cancer\
                                                                                                                         Breast cancer\
                                                                                                                         Cancer, unspecific\
                                                                                                                         Carcinoma in situ, unspecified\
                                                                                                                         Colorectal cancer\
                                                                                                                         Genitourinary tumors\
                                                                                                                         Lung cancer\
                                                                                                                         Malignant mesothelioma\
                                                                                                                         Meningioma\
                                                                                                                         Oropharyngeal squamous cell carcinoma\
                                                                                                                         Prostate cancer\
                                                                                                                         Renal cell carcinoma

                                                                                                                         

  Terpilene                                                                                                              Bladder cancer\
                                                                                                                         Breast cancer\
                                                                                                                         Cancer, unspecific\
                                                                                                                         Carcinoma in situ, unspecified\
                                                                                                                         Colorectal cancer\
                                                                                                                         Genitourinary tumors\
                                                                                                                         Lung cancer\
                                                                                                                         Malignant mesothelioma\
                                                                                                                         Meningioma\
                                                                                                                         Oesophageal cancer\
                                                                                                                         Oropharyngeal squamous cell carcinoma\
                                                                                                                         Pathological angiogenesis\
                                                                                                                         Gliomas\
                                                                                                                         Renal cell carcinoma\
                                                                                                                         Leukemia,\
                                                                                                                         Myeloid malignancies\
                                                                                                                         Prostate cancer\
                                                                                                                         Solid tumors

                                                                                                                         

  Guaiene                                                                                                                Bladder cancer\
                                                                                                                         Breast cancer\
                                                                                                                         Cancer, unspecific\
                                                                                                                         Carcinoma in situ, unspecified\
                                                                                                                         Colorectal cancer\
                                                                                                                         Genitourinary tumors\
                                                                                                                         Lung cancer\
                                                                                                                         Malignant mesothelioma\
                                                                                                                         Meningioma\
                                                                                                                         Oropharyngeal squamous cell carcinoma\
                                                                                                                         Prostate cancer\
                                                                                                                         Renal cell carcinoma

                                                                                                                         

  Salicylic acid                                                                                                         Bladder cancer\
                                                                                                                         Breast cancer\
                                                                                                                         Cancer, unspecific\
                                                                                                                         Carcinoma in situ, unspecified\
                                                                                                                         Carpal tunnel syndrome\
                                                                                                                         Colorectal cancer\
                                                                                                                         Genitourinary tumors\
                                                                                                                         Lung cancer\
                                                                                                                         Malignant mesothelioma Meningioma\
                                                                                                                         Oropharyngeal squamous cell carcinoma\
                                                                                                                         Prostate cancer\
                                                                                                                         Renal cell carcinoma\
                                                                                                                         Bronchiolar carcinoma\
                                                                                                                         Cervical cancer\
                                                                                                                         Chronic myeloid leukemia\
                                                                                                                         Gastrointestinal cancers\
                                                                                                                         Pancreatic cancer\
                                                                                                                         Urological cancers\
                                                                                                                         Leukemia, myeloid,\
                                                                                                                         Acute\
                                                                                                                         Endometrial carcinoma\
                                                                                                                         Leukemia, unspecified\
                                                                                                                         Mesothelioma\
                                                                                                                         Tumors\
                                                                                                                         Precursor\
                                                                                                                         Cell lymphoblastic\
                                                                                                                         Leukemia-lymphoma\
                                                                                                                         Breast neoplasms\
                                                                                                                         Non-small-cell lung carcinoma\
                                                                                                                         Colorectal neoplasms\
                                                                                                                         Gastrointestinal neoplasms\
                                                                                                                         Head and neck neoplasms\
                                                                                                                         Neoplasms\
                                                                                                                         Ovarian neoplasms\
                                                                                                                         Rectal neoplasms

                                                                                                                         

  (Z)-Caryophyllene                                                                                                      Bladder cancer\
                                                                                                                         Breast cancer\
                                                                                                                         Cancer, unspecific\
                                                                                                                         Carcinoma in situ, unspecified\
                                                                                                                         Colorectal cancer\
                                                                                                                         Genitourinary tumors\
                                                                                                                         Lung cancer\
                                                                                                                         Malignant mesothelioma\
                                                                                                                         Meningioma\
                                                                                                                         Oropharyngeal squamous cell carcinoma\
                                                                                                                         Prostate cancer\
                                                                                                                         Renal cell carcinoma

                                                                                                                         

  (*R*)-Linalool                                                                                                         Bladder cancer\
                                                                                                                         Breast cancer\
                                                                                                                         Cancer, unspecific\
                                                                                                                         Carcinoma in situ, unspecified\
                                                                                                                         Colorectal cancer\
                                                                                                                         Genitourinary tumors\
                                                                                                                         Lung cancer\
                                                                                                                         Malignant mesothelioma\
                                                                                                                         Meningioma\
                                                                                                                         Oropharyngeal squamous cell carcinoma\
                                                                                                                         Prostate cancer\
                                                                                                                         Renal cell carcinoma\
                                                                                                                         Acute promyelocytic leukemia\
                                                                                                                         Chronic myelogenous leukemia (CML)\
                                                                                                                         Gastrointestinal stromal tumors (GIST)\
                                                                                                                         Hematological malignancies\
                                                                                                                         HER2-positive\
                                                                                                                         Metastatic breast cancer\
                                                                                                                         Melanoma\
                                                                                                                         Multiple myeloma\
                                                                                                                         Non-small-cell lung cancer\
                                                                                                                         Ovarian cancer\
                                                                                                                         Refractory hematological malignancies\
                                                                                                                         Solid tumors

                                                                                                                         

  Mairin                                                                                                                 Breast cancer

                                                                                                                         

  Honokiol                                                                                                               Gliomas\
                                                                                                                         Breast cancer\
                                                                                                                         Prostate cancer\
                                                                                                                         Endocrine independent cancer\
                                                                                                                         Adrenocorticotropic hormone-secreting pituitary tumors\
                                                                                                                         Pancreatic cancer\
                                                                                                                         Bladder cancer\
                                                                                                                         Renal cell carcinoma\
                                                                                                                         Testicular cancer\
                                                                                                                         Thyroid follicular carcinoma\
                                                                                                                         Solid tumors\
                                                                                                                         Cancer, unspecific\
                                                                                                                         Carcinoma in situ, unspecified\
                                                                                                                         Colorectal cancer\
                                                                                                                         Genitourinary tumors\
                                                                                                                         Lung cancer\
                                                                                                                         Malignant mesothelioma\
                                                                                                                         Meningioma\
                                                                                                                         Refractory hematological malignancies\
                                                                                                                         Oropharyngeal squamous cell carcinoma\
                                                                                                                         Chronic myelogenous leukemia (CML)\
                                                                                                                         Malignancies\
                                                                                                                         Multiple myeloma\
                                                                                                                         Gastrointestinal stromal\
                                                                                                                         tumors (GIST)\
                                                                                                                         Hematological malignancies\
                                                                                                                         HER2-positive\
                                                                                                                         Metastatic breast cancer\
                                                                                                                         Melanoma\
                                                                                                                         Non-small-cell lung cancer\
                                                                                                                         Ovarian cancer\
                                                                                                                         Acute lymphoblastic leukemia (ALL)\
                                                                                                                         Acute myeloid leukemia (AML)\
                                                                                                                         Advanced solid tumors\
                                                                                                                         B-cell malignancies\
                                                                                                                         Chronic lymphocytic leukemia (CLL)\
                                                                                                                         Hepatocellular carcinoma (HCC)\
                                                                                                                         Nasopharyngeal cancer (NPC)\
                                                                                                                         Non-Hodgkin\'s lymphoma leukemia\
                                                                                                                         Myeloid\
                                                                                                                         Oesophageal cancer

                                                                                                                         

  Hemo-sol                                                                                                               Bladder cancer\
                                                                                                                         Breast cancer\
                                                                                                                         Cancer, unspecific\
                                                                                                                         Carcinoma in situ, unspecified\
                                                                                                                         Colorectal cancer\
                                                                                                                         Genitourinary tumors\
                                                                                                                         Lung cancer\
                                                                                                                         Malignant mesothelioma\
                                                                                                                         Meningioma\
                                                                                                                         Oropharyngeal squamous cell carcinoma\
                                                                                                                         Prostate cancer\

                                                                                                                         

  (1S,5S)-1-Isopropyl-4-methylenebicyclo\[3.1.0\]hexane                                                                  Bladder cancer\
                                                                                                                         Breast cancer\
                                                                                                                         Cancer, unspecific\
                                                                                                                         Carcinoma in situ, unspecified\
                                                                                                                         Colorectal cancer\
                                                                                                                         Genitourinary tumors\
                                                                                                                         Lung cancer\
                                                                                                                         Malignant mesothelioma\
                                                                                                                         Meningioma\
                                                                                                                         Oropharyngeal squamous cell carcinoma\
                                                                                                                         Prostate cancer\
                                                                                                                         Renal cell carcinoma

                                                                                                                         

  CHEBI:7                                                                                                                Chronic myeloid leukemia\
                                                                                                                         Breast cancer\
                                                                                                                         Bladder cancer\
                                                                                                                         Cancer, unspecific\
                                                                                                                         Carcinoma in situ, unspecified\
                                                                                                                         Colorectal cancer\
                                                                                                                         Genitourinary tumors\
                                                                                                                         Lung cancer\
                                                                                                                         Malignant mesothelioma\
                                                                                                                         Meningioma\
                                                                                                                         Oropharyngeal squamous cell carcinoma\
                                                                                                                         Prostate cancer\
                                                                                                                         Renal cell carcinoma\
                                                                                                                         Acute promyelocytic leukemia

                                                                                                                         

  Luteolin                                                                                                               Prostate cancer\
                                                                                                                         Bladder cancer\
                                                                                                                         Breast cancer\
                                                                                                                         Cancer, unspecific\
                                                                                                                         Carcinoma in situ, unspecified\
                                                                                                                         Colorectal cancer\
                                                                                                                         Genitourinary tumors\
                                                                                                                         Lung cancer\
                                                                                                                         Malignant mesothelioma\
                                                                                                                         Meningioma\
                                                                                                                         Oropharyngeal squamous cell carcinoma\
                                                                                                                         Renal cell carcinoma\
                                                                                                                         Chronic myelogenous\
                                                                                                                         leukemia (CML)\
                                                                                                                         Gastrointestinal stromal\
                                                                                                                         tumors (GIST)\
                                                                                                                         Hematological malignancies\
                                                                                                                         HER2-positive\
                                                                                                                         Metastatic breast cancer\
                                                                                                                         Melanoma\
                                                                                                                         Multiple myeloma\
                                                                                                                         Non-small-cell lung cancer\
                                                                                                                         Ovarian cancer\
                                                                                                                         Refractory hematological malignancies\
                                                                                                                         Solid tumors\
                                                                                                                         Malignancies\
                                                                                                                         Head and neck tumors\
                                                                                                                         Pancreatic cancer\
                                                                                                                         Solid tumor\
                                                                                                                         Squamous cell carcinoma tumors\
                                                                                                                         Colorectal neoplasms\
                                                                                                                         Brain cancer\
                                                                                                                         Hepatocellular carcinoma\
                                                                                                                         Hormone-refractory prostate cancer\
                                                                                                                         Kaposi\'s sarcoma\
                                                                                                                         Cancer (multidrug-resistant)\
                                                                                                                         Kidney cancer\
                                                                                                                         Chondrosarcoma\
                                                                                                                         Breast neoplasms\
                                                                                                                         Non-small-cell lung carcinoma\
                                                                                                                         Gastrointestinal neoplasms\
                                                                                                                         Head and neck neoplasms\
                                                                                                                         Neoplasms\
                                                                                                                         Ovarian neoplasms\
                                                                                                                         Precursor cell\
                                                                                                                         Lymphoblastic leukemia-lymphoma\
                                                                                                                         Rectal neoplasms\
                                                                                                                         Gastric cancer\
                                                                                                                         Prostate cancer (metastatic)\
                                                                                                                         Small-cell lung cancer

                                                                                                                         

  HCI                                                                                                                    Gliomas\
                                                                                                                         Bladder cancer\
                                                                                                                         Breast cancer\
                                                                                                                         Cancer, unspecific\
                                                                                                                         Carcinoma in situ, unspecified\
                                                                                                                         Colorectal cancer\
                                                                                                                         Genitourinary tumors\
                                                                                                                         Lung cancer\
                                                                                                                         Malignant mesothelioma\
                                                                                                                         Meningioma\
                                                                                                                         Oropharyngeal squamous cell carcinoma\
                                                                                                                         Prostate cancer\
                                                                                                                         Renal cell carcinoma\
                                                                                                                         Malignancies

                                                                                                                         

  Beta-selinene                                                                                                          Bladder cancer\
                                                                                                                         Breast cancer\
                                                                                                                         Cancer, unspecific\
                                                                                                                         Carcinoma in situ, unspecified\
                                                                                                                         Colorectal cancer\
                                                                                                                         Genitourinary tumors\
                                                                                                                         Lung cancer\
                                                                                                                         Malignant mesothelioma\
                                                                                                                         Meningioma\
                                                                                                                         Oropharyngeal squamous cell carcinoma\
                                                                                                                         Prostate cancer\
                                                                                                                         Renal cell carcinoma

                                                                                                                         

  2-Methyl-*N*-phenylmaleimide                                                                                           Cancer, unspecific\
                                                                                                                         Tumors\
                                                                                                                         Bladder cancer\
                                                                                                                         Breast cancer\
                                                                                                                         Carcinoma in situ, unspecified\
                                                                                                                         Colorectal cancer\
                                                                                                                         Genitourinary tumors\
                                                                                                                         Lung cancer\
                                                                                                                         Prostate cancer\
                                                                                                                         Renal cell carcinoma\
                                                                                                                         Pancreatic cancer\
                                                                                                                         Chronic myeloid leukemia\
                                                                                                                         Oesophageal cancer

                                                                                                                         

  2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-3-\[(2R,3R,4S,5R)-3,4,5-trihydroxytetrahydropyran-2-yl\]oxy-chromone             Bladder cancer\
                                                                                                                         Breast cancer\
                                                                                                                         Cancer, unspecific\
                                                                                                                         Carcinoma in situ, unspecified\
                                                                                                                         Colorectal cancer\
                                                                                                                         Genitourinary tumors\
                                                                                                                         Lung cancer\
                                                                                                                         Malignant mesothelioma\
                                                                                                                         Meningioma\
                                                                                                                         Prostate cancer\
                                                                                                                         Meningioma\
                                                                                                                         Renal cell carcinoma\
                                                                                                                         Oropharyngeal squamous cell carcinoma\
                                                                                                                         Acute promyelocytic leukemia

                                                                                                                         

  Anethole                                                                                                               Glaucoma\
                                                                                                                         Breast cancer\
                                                                                                                         Cancer (multidrug-resistant)\
                                                                                                                         Melanoma

                                                                                                                         

  (+)-Catechin                                                                                                           Breast cancer\
                                                                                                                         Endocrine independent cancer\
                                                                                                                         Bladder cancer\
                                                                                                                         Cancer, unspecific\
                                                                                                                         Colorectal cancer\
                                                                                                                         Genitourinary tumors\
                                                                                                                         Lung cancer\
                                                                                                                         Malignant mesothelioma\
                                                                                                                         Meningioma\
                                                                                                                         Oropharyngeal squamous cell carcinoma\
                                                                                                                         Prostate cancer\
                                                                                                                         Renal cell carcinoma\
                                                                                                                         Chronic myelogenous leukemia (CML)\
                                                                                                                         Refractory hematological malignancies\
                                                                                                                         Gastrointestinal stromal tumors (GIST)\
                                                                                                                         Precursor cell\
                                                                                                                         Lymphoblastic leukemia-lymphoma\
                                                                                                                         Hematological malignancies\
                                                                                                                         HER2-positive\
                                                                                                                         Metastatic breast cancer\
                                                                                                                         Melanoma\
                                                                                                                         Non-small-cell lung cancer\
                                                                                                                         Ovarian cancer\
                                                                                                                         Solid tumors

                                                                                                                         

  Shikimic acid                                                                                                          Bladder cancer\
                                                                                                                         Breast cancer\
                                                                                                                         Cancer, unspecific\
                                                                                                                         Carcinoma in situ, unspecified\
                                                                                                                         Colorectal cancer\
                                                                                                                         Genitourinary tumors\
                                                                                                                         Lung cancer\
                                                                                                                         Malignant mesothelioma\
                                                                                                                         Meningioma\
                                                                                                                         Oropharyngeal squamous cell carcinoma\
                                                                                                                         Prostate cancer\
                                                                                                                         Renal cell carcinoma

                                                                                                                         

  Astragalin                                                                                                             Bladder cancer\
                                                                                                                         Breast cancer\
                                                                                                                         Cancer, unspecific\
                                                                                                                         Carcinoma in situ, unspecified\
                                                                                                                         Colorectal cancer\
                                                                                                                         Lung cancer\
                                                                                                                         Genitourinary tumors\
                                                                                                                         Prostate cancer\
                                                                                                                         Malignant mesothelioma\
                                                                                                                         Meningioma\
                                                                                                                         Oropharyngeal squamous cell carcinoma\
                                                                                                                         Renal cell carcinoma\
                                                                                                                         Acute promyelocytic leukemia\
                                                                                                                         Chronic myelogenous leukemia (CML)\
                                                                                                                         Gastrointestinal stromal tumors (GIST)\
                                                                                                                         Hematological malignancies\
                                                                                                                         HER2-positive\
                                                                                                                         Metastatic breast cancer\
                                                                                                                         Melanoma\
                                                                                                                         Multiple myeloma\
                                                                                                                         Non-small-cell lung cancer\
                                                                                                                         Ovarian cancer\
                                                                                                                         Refractory hematological malignancies\
                                                                                                                         Solid tumors\
                                                                                                                         Gliomas\
                                                                                                                         Malignancies

                                                                                                                         

  Cis-beta-farnesene                                                                                                     Bladder cancer\
                                                                                                                         Breast cancer\
                                                                                                                         Cancer, unspecific\
                                                                                                                         Carcinoma in situ, unspecified\
                                                                                                                         Colorectal cancer\
                                                                                                                         Meningioma\
                                                                                                                         Genitourinary tumors\
                                                                                                                         Malignant mesothelioma\
                                                                                                                         Lung cancer\
                                                                                                                         Oropharyngeal squamous cell carcinoma\
                                                                                                                         Prostate cancer\
                                                                                                                         Renal cell carcinoma

                                                                                                                         

  5,7-Dihydroxy-2-(4-hydroxyphenyl)-3-\[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl\]oxychromen-4-one   Acute promyelocytic leukemia\
                                                                                                                         Cancer, unspecific

                                                                                                                         

  Beta-bisabolene                                                                                                        Bladder cancer\
                                                                                                                         Prostate cancer\
                                                                                                                         Breast cancer\
                                                                                                                         Cancer, unspecific\
                                                                                                                         Renal cell carcinoma\
                                                                                                                         Colorectal cancer\
                                                                                                                         Carcinoma in situ, unspecified\
                                                                                                                         Genitourinary tumors\
                                                                                                                         Lung cancer\
                                                                                                                         Malignant mesothelioma\
                                                                                                                         Meningioma\
                                                                                                                         Oropharyngeal squamous cell carcinoma

                                                                                                                         

  Quercetin                                                                                                              Prostate cancer\
                                                                                                                         Bladder cancer\
                                                                                                                         Pancreatic cancer\
                                                                                                                         Renal cell carcinoma\
                                                                                                                         Adrenocorticotropic hormone-secreting pituitary tumors\
                                                                                                                         Testicular cancer\
                                                                                                                         Thyroid follicular carcinoma\
                                                                                                                         Breast cancer\
                                                                                                                         Cancer, unspecific\
                                                                                                                         Carcinoma in situ, unspecified\
                                                                                                                         Colorectal cancer\
                                                                                                                         Malignant mesothelioma\
                                                                                                                         Meningioma\
                                                                                                                         Urinary bladder neoplasms\
                                                                                                                         Genitourinary tumors\
                                                                                                                         Lung cancer\
                                                                                                                         Melanoma\
                                                                                                                         Multiple myeloma\
                                                                                                                         Non-small-cell lung cancer Oropharyngeal squamous cell carcinoma\
                                                                                                                         Ovarian cancer\
                                                                                                                         Chronic myelogenous leukemia (CML)\
                                                                                                                         Solid tumors\
                                                                                                                         Hematological malignancies\
                                                                                                                         Malignancies\
                                                                                                                         Gastrointestinal stromal tumors (GIST)\
                                                                                                                         Gliomas\
                                                                                                                         HER2-positive\
                                                                                                                         Metastatic breast cancer\
                                                                                                                         Brain cancer\
                                                                                                                         Colon cancer\
                                                                                                                         Solid tumor\
                                                                                                                         Refractory hematological malignancies\
                                                                                                                         Tumor\
                                                                                                                         Acute promyelocytic leukemia\
                                                                                                                         Kaposi\'s sarcoma\
                                                                                                                         Head and neck tumors\
                                                                                                                         Rectal neoplasms\
                                                                                                                         Cancer (multidrug-resistant)\
                                                                                                                         Kidney cancer\
                                                                                                                         Squamous cell carcinoma\
                                                                                                                         Colorectal neoplasms\
                                                                                                                         Breast neoplasms\
                                                                                                                         Ovarian neoplasms\
                                                                                                                         Chronic lymphocytic leukemia\
                                                                                                                         Hormone-refractory prostate cancer\
                                                                                                                         Waldenstrom\'s macroglobulinemia\
                                                                                                                         Endometrial neoplasms\
                                                                                                                         Hepatocellular carcinoma\
                                                                                                                         Chondrosarcoma\
                                                                                                                         Bronchiolar carcinoma\
                                                                                                                         Urological cancers\
                                                                                                                         Non-small-cell lung carcinoma\
                                                                                                                         Gastrointestinal neoplasms\
                                                                                                                         Head and neck neoplasms\
                                                                                                                         Cervical cancer\
                                                                                                                         Chronic myeloid leukemia\
                                                                                                                         Gastrointestinal cancers\
                                                                                                                         Neoplasms\
                                                                                                                         Precursor cell lymphoblastic leukemia-lymphoma

                                                                                                                         

  Terragon                                                                                                               Cancer, unspecific\
                                                                                                                         Bladder cancer\
                                                                                                                         Breast cancer\
                                                                                                                         Carcinoma in situ, unspecified\
                                                                                                                         Colorectal cancer\
                                                                                                                         Genitourinary tumors\
                                                                                                                         Lung cancer\
                                                                                                                         Malignant mesothelioma\
                                                                                                                         Meningioma\
                                                                                                                         Oropharyngeal squamous cell carcinoma\
                                                                                                                         Prostate cancer\
                                                                                                                         Renal cell carcinoma

                                                                                                                         

  Humulene                                                                                                               Bladder cancer\
                                                                                                                         Breast cancer\
                                                                                                                         Cancer, unspecific\
                                                                                                                         Carcinoma in situ, unspecified\
                                                                                                                         Colorectal cancer\
                                                                                                                         Genitourinary tumors\
                                                                                                                         Lung cancer\
                                                                                                                         Malignant mesothelioma\
                                                                                                                         Meningioma\
                                                                                                                         Prostate cancer\
                                                                                                                         Solid tumor
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

The 10 CML-related compounds of Anisi stellati fructus.

  Molecule name                  MW       OB (%)   Caco-2   DL     HL
  ------------------------------ -------- -------- -------- ------ -------
  Astragalin                     448.41   14.03    −1.34    0.74   N/A
  CHEBI:7                        136.26   45.2     1.84     0.04   11.44
  (+)-Catechin                   290.29   54.83    −0.03    0.24   0.61
  2-Methyl-*N*-phenylmaleimide   187.21   87.36    0.77     0.06   2.93
  Kaempferol                     286.25   41.88    0.26     0.24   14.74
  Honokiol                       266.36   60.67    1.43     0.15   2.88
  Luteolin                       286.25   36.16    0.19     0.25   15.94
  Salicylic acid                 138.13   32.13    0.63     0.03   12
  (*R*)-Linalool                 154.28   39.8     1.33     0.02   6.48
  Quercetin                      302.25   46.43    0.05     0.28   14.4

MW: molecular weight; OB: oral bioavailability; Caco-2: Caco-2 permeability; DL-2: drug likeness; HL: drug half-life.

[^1]: Academic Editor: Ho Lin
